Long-term study of an experimental COPD treatment
Part of Lungs & breathing clinical trials.
This study continues from an earlier trial to see if the experimental medicine tilrekimig remains safe and works well over a longer period for people with moderate-to-severe COPD. If you took part in the previous study, you might be able to join this one.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have completed the earlier study of this medicine (called C4531031).
- If you can become pregnant, you must agree to use a highly effective birth control method.
- You must not have any ongoing serious side effects from the previous study.
- You must not have any other medical, mental health, or behavioral condition that could make participation risky.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
This study tests an investigational medicine called tilrekimig for people with severe asthma that is not well controlled. The goal is to see if it can reduce asthma attacks and improve breathing.
This study tests an investigational medicine called tilrekimig for people with severe asthma that isn't well controlled. It aims to reduce asthma attacks and improve breathing.
This study tests an experimental medication for chronic obstructive pulmonary disease (COPD) in two parts: first in healthy volunteers, then in people with COPD. It aims to see if the drug is safe and how well it works.
This study tests an investigational medicine called Tilrekimig for people with moderate-to-severe eczema (atopic dermatitis) that hasn't improved with standard treatments. It aims to see if the medicine can reduce symptoms and improve quality of life.
This study tests an experimental drug for people with moderate to severe COPD, especially those with chronic bronchitis. It aims to see how the drug affects certain markers in your body and whether it helps with your COPD symptoms.
Hear when a new Moderate to Severe Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.